Document is current
Any future updates will be listed below
-
Authors
Bruxvoort, Katia https://orcid.org/0000-0001-8277-2431
Portugal, Cecilia
Munis, Mercedes
Pak, Katherine
Hechter, Rulin
-
Funding
Funding for this research was provided by:
Gilead Sciences
- License Information
-
More Information
Article History
Accepted: 5 January 2023
First Online: 17 January 2023
Declarations
:
: Katia Bruxvoort has received funding from Dynavax, GlaxoSmithKline, Moderna, Pfizer, and Seqirus for research unrelated to this study. All other authors have no competing interests.
: The study was approved by the KPSC Institutional Review Board (IRB #12482).
: The requirement for written informed consent was waived by the KPSC IRB due to minimal risk to study participants. Individuals who voluntarily completed the survey provided tacit agreement to participate. Individuals who participated in qualitative interviews provided verbal agreement prior to participation.
: N/A.
